U.S. Logistics Stock News

NasdaqGS:CVBF
NasdaqGS:CVBFBanks

CVB Financial (CVBF) Gets A Zacks Upgrade, Is An 11% Discount Still Justified?

CVB Financial (CVBF) drew fresh attention after Zacks upgraded the stock to a Rank #2, based on an upward trend in earnings estimates over the past three months. At a share price of $22.39, CVB Financial has slipped over the past week with a 7 day share price return of 2.82% and is slightly down over the past month, yet the 90 day share price return of 9.27% and year to date share price return of 19.93% point to building momentum. The 1 year total shareholder return of 15.06% and 3 year total...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is Elanco (ELAN) Quietly Reframing Its Pet Therapeutics Strategy With This Kansas Antibody Expansion?

Elanco Animal Health has completed a 25,000-square-foot, US$120 million manufacturing expansion at its Elwood, Kansas site, quadrupling monoclonal antibody capacity and adding a pilot plant, new quality control lab and support spaces, with a further US$30 million warehousing investment planned through 2028. This enlarged facility underpins production of Elanco’s new monoclonal antibody treatments Befrena and Trutect, reinforcing its push into advanced pet therapeutics as pet owners demand...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Could Be 31% Above Fair Value After Its Sharp Rally

10x Genomics (TXG) has drawn investor attention after recent share price gains over the past month and past 3 months. The stock closed at $64.72 on 26 August 2026, with recent returns significantly higher than its 1-year figure. For you as an investor, the recent momentum in 10x Genomics is hard to ignore. The 30 day share price return is 39.87% and the 90 day share price return is 153.70%, while the 1 year total shareholder return of 361.30% contrasts with a 5 year total shareholder return...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Stock Trades At A Discount On Cash Flow And Earnings

Luckin Coffee stock has produced strong long term gains over the past five years, while current valuation checks suggest the shares may still trade below an estimate of intrinsic value. For investors, the key issue is how much confidence to place in that apparent discount. Over five years, Luckin Coffee has returned 172.2%, which puts the recent share price in the context of a meaningful longer run gain already on the table. The main potential support for valuation is the company’s ability...
NYSE:APD
NYSE:APDChemicals

Eaton Stock And 2 Global Industrials Tied To A Weaker Dollar

When Fed Chair Kevin Warsh steps up in Jackson Hole with inflation still at 3.7% and long term yields in focus, the stakes for global exporters and commodity producers rise sharply. Potential dollar weakness or strength could reshape where returns come from next, especially for companies earning abroad. This article walks through three stocks exposed to that macro crosswind and explains how each might fit, or might not fit, in your portfolio plan. The three stocks below are only a starting...
NYSE:RKT
NYSE:RKTDiversified Financial

Rocket Companies (RKT) Following Board News Still Looks Undervalued In The Bull Case

Rocket Companies (RKT) is back in focus after appointing Sarah Watterson as an independent director to its board. She brings more than 15 years of executive leadership and capital markets experience to the mortgage and real estate platform. Recent product and regulatory updates around Redfin and Rocket Money have put Rocket Companies back on traders' radars. The latest share price of US$14.30 reflects mixed momentum, with a 30 day share price return of 9.58% contrasting with a year to date...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

Why Is BridgeBio Pharma (BBIO) Presenting New Acoramidis Data At ESC 2026?

BridgeBio Pharma (NasdaqGS: BBIO) plans to present new acoramidis data from open-label extension analyses in ATTR-CM at ESC Congress 2026. The update focuses on clinical outcomes and real-world efficacy following recent broad regulatory approvals for acoramidis. The presentation is aimed at cardiology specialists and could influence future treatment use and healthcare decision making in ATTR-CM. The focus on fresh clinical data in ATTR-CM is part of a wider push toward evidence-rich...
NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab (SCHW) Stock Could Be 11% Below Fair Value Following July Asset Growth

Charles Schwab stock has almost doubled over the past three years, and the valuation checks now point to a more balanced picture. The Excess Returns intrinsic value estimate suggests the shares trade at a modest discount, while traditional market multiples look broadly in line with peers. Schwab’s 96.8% return over three years puts the recent share performance in focus and raises the question of how much upside may already be reflected in the price. Strong recent client activity and product...
NasdaqGS:MRTN
NasdaqGS:MRTNTransportation

Following Credit Agreement Update, Is Marten Transport (MRTN) Now Fully Valued?

Marten Transport (MRTN) has expanded its financing capacity through a revised unsecured revolving credit agreement with U.S. Bank and partner lenders. The update extends access to liquidity and refreshes key terms for general business and working capital needs. Marten Transport’s latest credit agreement update comes after a softer patch for the stock. The 30-day share price return is down 11.10% and the 90-day share price return is down 16.00%. By contrast, the year-to-date share price return...
NasdaqGS:ZG
NasdaqGS:ZGReal Estate

What’s Behind Zillow Group (ZG) Shares Moving Today?

Zillow Group (ZG) resolved a lawsuit with the Federal Trade Commission and several states over its multifamily rental syndication agreement with Redfin. The settlement keeps their partnership intact and removes a legal overhang. Zillow Group's latest legal resolution comes as the share price trades at $37.09, with a 1 month share price return of 20.89% and a 7 day share price return of 5.13%, yet the year to date share price return is down 43.47% and the 1 year total shareholder return has...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Is Columbia Banking System (COLB) Undervalued Following Its Dividend Reaffirmation?

Columbia Banking System (COLB) recently reaffirmed its shareholder return policy, with the Board approving a quarterly cash dividend of $0.37 per share, payable on September 14, 2026, to shareholders of record on August 28. At a share price of $30.53, Columbia Banking System has seen short term share price pressure, with a 7 day share price return down 5.01%, even though the year to date share price return is up 8.30% and the 1 year total shareholder return is 18.98%. Position your dividend...
NYSE:CMC
NYSE:CMCMetals and Mining

Commercial Metals (CMC) Stock Looks Cheap After a 119% Five Year Run

Commercial Metals has delivered strong share gains over the past five years, yet the current valuation checks still suggest the stock may be pricing in less than its full intrinsic value. At the recent close of US$66.85, both market based multiples and an intrinsic value estimate for Commercial Metals point to a stock that screens as cheap rather than fully valued. Over the past 5 years Commercial Metals has returned 119.3%, which puts recent short term share price weakness into the context...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

What Is CME Group (CME) Signaling With Its First U.S. Zinc Futures Trades?

CME Group (NasdaqGS:CME) reported the first trades of its updated U.S. Zinc Futures contract, which is structured as a U.S. duty-paid product. Major commodities firms Glencore and Trafigura took part in the initial transactions, signalling early interest from large industry participants. The new contract is designed to offer more accurate local pricing and risk management tools for the U.S. zinc market. For readers tracking how new hedging tools and infrastructure shape real-world demand,...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Is Concentrix (CNXC) Trading Growth for Too Little Profitability in Its Evolving Investment Story?

Concentrix, a global customer experience solutions provider, has recently come under scrutiny as its trailing 12‑month GAAP operating margin stands at 10.2% and earnings per share have fallen, raising questions about the efficiency of its recent growth. These trends, combined with weak returns on capital, have intensified concerns that management is struggling to convert incremental sales into sustainable, profitable expansion. We’ll now examine how concerns over management’s ability to...
NYSE:C
NYSE:CBanks

Citigroup (C) After Fresh Analyst Optimism And New Notes Looks Undervalued But Is It Priced In

Citigroup (C) is back in focus after announcing a new zero coupon senior unsecured note offering due 2056, as investors weigh how this financing move, recent platform launches and ongoing restructuring could shape the upcoming earnings report. Citigroup’s share price has eased 3.2% over the past week but still shows a 6.3% 90 day share price return and a 12.3% year to date share price return, while the 1 year total shareholder return of 42.2% and very large 3 year total shareholder return...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Veeva Systems (VEEV) Lands Two Global Vault CRM Customers

Veeva Systems (NYSE:VEEV) said Regeneron Pharmaceuticals and Biogen have selected Veeva Vault CRM for their global operations in new partnerships. The agreements expand adoption of Veeva's AI powered commercial platform among large pharmaceutical companies. The new deals follow earlier news on Eli Lilly's commitment to Vault CRM and changes in Veeva's sales leadership. Readers watching Veeva's AI driven software footprint in life sciences may also want to review other stocks tied to the...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Will AI Security Standards And Confidential Computing Moves Change Advanced Micro Devices' (AMD) Narrative?

In recent days, the Linux Foundation said it is taking stewardship of TRACE, an open hardware-attested evidence standard for AI and confidential workloads co-developed by AMD, Intel, Microsoft, OPAQUE and TII, while Anjuna Security launched its Seaglass confidential computing platform on AMD EPYC CPUs using AMD Secure Virtualization. Together with fresh analyst enthusiasm for AMD’s role in AI server CPUs and agentic AI workloads, these moves highlight how AMD is tying its silicon to emerging...
NYSE:AIR
NYSE:AIRAerospace & Defense

AAR (AIR), Why Is The Market Taking Another Look?

AAR (AIR) has drawn investor attention after its recent share price performance, with the stock last closing at US$135.36. The move comes against a backdrop of aviation and defense activity across AAR’s commercial and government customer base. While AAR’s share price slipped 9.17% over the past week, the stock still shows strong momentum with a 4.89% 1 month share price return and a 19.98% 3 month share price return, along with a 76.27% 1 year total shareholder return and 299.88% 5 year total...
NasdaqGS:KSPI
NasdaqGS:KSPIConsumer Finance

High Yield Dividend Stocks Backed By Recurring Cash Flow

Germany’s business sentiment has improved to a one year high, even as energy price risks and the Middle East conflict keep investors cautious. That mix of resilience and concern is where Dividend Fortresses can matter. Reliable 5%+ yields can help steady a portfolio when growth signals look uneven. This article highlights three Dividend Fortresses stocks that currently fit that brief and explains what sets each apart. The Dividend Fortresses stocks in this article are just a starting sample,...
NYSE:LNN
NYSE:LNNMachinery

Lindsay (LNN) Stock May Be 28% Undervalued On Cash Flow

Lindsay stock presents a mixed picture on valuation today. The Discounted Cash Flow (DCF) intrinsic value estimate points to upside relative to the market price, while the earnings multiples suggest the shares trade at a richer level than the fundamentals may justify. Over the past 5 years the share price has fallen 26.8%, which points to weak long term returns for investors who have held through that period. Future cash flow growth and margin quality in Lindsay's irrigation and...
NasdaqGS:STBA
NasdaqGS:STBABanks

S&T Bancorp (STBA) Stock Looks Like A Bargain On Returns Yet Full On Earnings

S&T Bancorp stock has more than doubled over the past five years, yet the current valuation checks send mixed signals. The Excess Returns intrinsic value estimate points to a meaningful discount to fair value, while market based multiples suggest the shares trade on the rich side. Over the past 5 years S&T Bancorp has returned 102.2%, which puts extra attention on whether today’s price still leaves room for attractive long term returns. For a regional bank, the strength and consistency of...
NYSE:KAI
NYSE:KAIMachinery

Kadant (KAI) Stock May Be Fully Priced Despite Its 48% Run

Kadant stock has delivered a solid 5 year return, yet the valuation picture today is more balanced, with the intrinsic value estimate sitting close to the current share price while traditional market multiples lean rich. For investors looking at Kadant now, the question is less about past gains and more about whether the current price fairly reflects its future cash flow potential. Over the past 5 years, Kadant has returned about 48.4%, which suggests the market has already priced in a...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) Could Be 9% Undervalued Following Court Sanctions And Legal Risk Questions

A California Workers' Compensation Appeals Board judge recently sanctioned Lyft (LYFT) for willfully delaying discovery and acting with malice in a catastrophic driver injury case, sharpening investor focus on its gig worker classification model. Lyft shares trade at US$17.65 and have shown strong near term momentum, with a 30 day share price return of 24.3% and a 90 day return of 28.83%. However, the year to date share price return is down 10.81% and the 5 year total shareholder return is...